Company intelligence / Profile preview

Watson International Limited

London, London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Watson International Limited is recognized as a global manufacturer and supplier of high-purity chemical linkers—especially PEG linkers—used in the development of antibody-drug conjugates for top pharma and biotech clients. The company supports projects from gram-scale R&D to GMP multi-kilogram production, with a strong reputation for quality, scalability, and regulatory compliance

Modalities: PEG linkerAntibody-drug conjugateSmall molecule building blocks
Industry: Chemicals & Materials

Partnerships

Long-term supplier to global pharma and biotech companies developing antibody-drug conjugates (names not publicly disclosed)

Beyond the preview

Go deeper on Watson International Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Watson International Limited.

Explore the full profile